Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

NSE/SANOFICONR stock hub

NSE/SANOFICONR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/SANOFICONRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

109.8B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/SANOFICONR

In the news

Latest news · NSE/SANOFICONR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E39.5

P25 24.9P50 32.4P75 45.7

Trailing P/E42.6

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC715.6

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/SANOFICONR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

155

Groups with data

Currency

INR

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	583
Enterprise value	INR 106.3B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	INE0UOS01011
Last refreshed	2026-05-10
Market cap	INR 109.8B
Price	INR 4,775
Price currency	INR
Sector	Healthcare
Sic	2834
Symbol	nse/SANOFICONR
Website	https://www.sanofi.com/en/Consumer-Healthcare/health-and-well-being

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.35%
EV Earnings	41.22x
EV/EBIT	33.13x
EV/EBITDA	31.73x
EV/Sales	11.37x
Forward P/E	39.47x
P/B ratio	28.59x
P/E ratio	42.56x
P/S ratio	11.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.32%
EBITDA Margin	35.83%
Gross margin	73.53%
Gross Profit	INR 6.9B
Gross Profit Growth	35.07%
Gross Profit Growth Q	29.3%
Net Income	INR 2.6B
Net Income Growth	53.24%
Net Income Growth Q	35.6%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	36.81%
Profit Margin	27.58%
Profitable Years	1
ROIC	715.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-3.62%
EPS Growth	37.46
EPS Growth Q	35.73
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth	38.42x
Revenue Growth Q	32.79x
Revenue Growth Quarters	3x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 3.8B
Debt	INR 248M
Debt EBITDA	INR 0.07
Debt Equity	INR 0.06
Equity	INR 3.8B
Interest Coverage	152.8
Net Cash	INR 3.5B
Net Cash By Market Cap	INR 3.19
Net Cash Growth	14.29%
Net Debt EBITDA	INR -1.05
Net Debt Equity	INR -0.91
Tangible Book Value	INR 3.8B
Tangible Book Value Per Share	INR 166

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.48%
Dividend Growth Years	1%
Dividend per share	INR 75
Dividend Years	1
Dividend Yield	1.57%
Last Dividend	INR 55

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-3.61%
200-day SMA	4,659.1
50-day SMA	4,455.6
50-day SMA vs 200-day SMA	50under200
All Time High	5,894.5
All Time High Change	-18.99%
All Time High Date	2025-06-30
All Time Low	3,975
All Time Low Change	20.13%
All Time Low Date	2026-02-24
ATR	160.1
Beta1y	0.29
Beta2y	0.21
Ch YTD	5.64
High	4,798.9
High52	5,894.5
High52 Date	2025-06-30
High52ch	-18.99%
Low	4,684.2
Low52	3,975
Low52 Date	2026-02-24
Low52ch	20.13%
Ma50ch	7.17%
Price vs 200-day SMA	2.49%
RSI	59.45
RSI Monthly	47.34
RSI Weekly	56.05
Sharpe ratio	-0.05x
Sortino ratio	0.12
Total Return	-9.91%
Tr YTD	5.64
Tr1m	5.4%
Tr1w	0.78%
Tr3m	12.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 3.2B
Operating Income Growth	29.81
Operating Income Growth Q	38.06
Operating margin	34.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,573,477%
Shares Institutions	25.38%
Shares Out	23,030,622
Shares Qo Q	-0.02%
Shares Yo Y	11.48%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	9,407.55x
Bv Per Share	166.7
Ch1m	5.4
Ch1w	0.78
Ch1y	-3.61
Ch3m	12.3
Ch6m	2.85
Change	0.3%
Change From Open	1.41
Close	4,760.7
Days Gap	-1.09
Depreciation Amortization	140,750,000
Dollar Volume	22,705,125
Earnings Date	2026-04-28
EBIT	INR 3.2B
EBITDA	INR 3.3B
EPS	INR 112
F Score	1
Fiscal Year End	December
Founded	2,023
Graham Number	648.23292
Graham Upside	-86.42
Income Tax	INR 863M
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Ma150	4,502.7
Ma150ch	6.05%
Ma20	4,676.2
Ma20ch	2.11%
Next Earnings Date	2026-08-04
Open	4,708.7
Payment Date	2025-06-04
Position In Range	79.16
Price Date	2026-05-08
Price EBITDA	INR 32.78
Ptbv Ratio	28.65
Relative Volume	0.51x
Revenue	9,350,000,000x
Tax By Revenue	9.23x
Tax Rate	25.07%
Tr6m	2.85%
Volume	4,755

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/SANOFICONR dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.6%

$75.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-9.9%

Dividend yield + buyback yield combined

Performance

NSE/SANOFICONR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/SANOFICONR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.4%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+11.5%

Negative means the company is buying back shares.

Technical

NSE/SANOFICONR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.4

Neutral momentum band

Price vs 200-day MA

+2.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/SANOFICONR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/SANOFICONR stock rating?

nse/SANOFICONR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/SANOFICONR analysis?

The full report lives at /stocks/nse/SANOFICONR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/SANOFICONR?

The latest report frames nse/SANOFICONR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/SANOFICONR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.